1 FTSE 100 growth stock I’d buy today

Royston Wild looks at a FTSE 100 (INDEXFTSE: UKX) share with brilliant growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2017 been a year to remember for Schroders (LSE: SDR), its share price having leapt 17% since the start of January and seeing it take out the record levels set way back in mid-2015.

The financial asset manager’s all-time high now stands at £35.27 per share, set just before Christmas, and I can easily see it continuing to surge in the new year.

Business keeps on tearing higher at Schroders, the FTSE 100 giant reporting a 9% uptick in assets under management and administration during January-September, to £430bn. And I am confident that expansion into hot growth territories should keep inflows moving northwards.

City analysts share my bullish take, and they expect Schroders’ long-running growth story to continue, with bottom line rises of 11% and 6% pencilled in for 2017 and 2018.

What’s more, there is plenty for income chasers to get their teeth into over at Schroders. The business has lifted dividends by 116% over the past five years, and with earnings predicted to keep sprinting and the firm boasting a robust balance sheet, dividends are expected to jump from 93p in 2016 to 104.1p this year and 110.5p in 2018.

As a consequence yields clock in a healthy 3.1% and 3.2% for 2017 and 2018 respectively.

Despite its rapid share price ascent Schroders can still be picked up on an undemanding prospective P/E ratio of 16.8 times and a corresponding PEG reading of 1.5. I reckon this is a steal given the company’s impressive momentum.

Take a bite

I reckon those seeking delicious earnings growth should also give Patisserie Holdings (LSE: CAKE) a close look today.

Thanks to its ongoing expansion programme (it opened 20 new stores in the year to September, taking the total to just shy of 200) the AIM-quoted firm saw revenues shoot 9.7% higher in the period, to £114.2m.

Patisserie Holdings aims to open a similar number of stores in the current fiscal period, a drive that is seeing it look beyond the borders of England to generate sales growth. The company opened two new stores in the Republic of Ireland last year, two in Scotland and one in Northern Ireland.

But rampant sales growth is only one side of the story as, thanks to its tight grip on costs, Patisserie Holdings is also managing to deal with an environment of rising labour and ingredient costs. As a consequence the business saw pre-tax profit explode 17.1% last year to £20.2m.

So City analysts are expecting the Birmingham business to keep doling out bright double-digit earnings growth, and they are forecasting a 12% earnings improvement in the year to September 2018.

While a subsequent forward P/E ratio of 20 times may look a tad toppy on paper, a corresponding PEG readout of 1.7 can hardly be considered unreasonable.

What’s more, Patisserie Holdings is also giving the impression of being a future cash cow given the rate at which it is raising dividends. The business hiked the full-year dividend 19.8% in fiscal 2017, to 2.4p, and another hefty hike — to 4.1p — is forecast for the present period. As a consequence investors can also enjoy a handy 1.1% yield.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Patisserie Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »